01 1Alivus Life Sciences
01 1ZONISAMIDE USP (D270 PROCESS)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-10-31
Pay. Date : 2022-10-25
DMF Number : 31973
Submission : 2017-09-27
Status : Active
Type : II
20
Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ZONISAMIDE USP (D270 PROCESS), with a corresponding US DMF Number 31973.
Remarkably, this DMF maintains an Active status since its submission on September 27, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 31, 2022, and payment made on October 25, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
